跳至主要内容
临床试验/NCT03177317
NCT03177317已完成不适用

A Feasibility Study of Reduced Dose of Prophylactic Dexamethasone for Elderly Patients Receiving Moderate Emetogenic Chemotherapies

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Complete response (CR)

研究概览

简要总结

Feasibility study to evaluate the efficacy of reduced prophylactic dose of dexamethasone in elderly patients receiving moderate emetogenic chemotherapy

详细描述

The purpose of this trial is to determine if the dose of dexamethasone used as an antiemetic drug in patients with advanced cancer could be safely reduced.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
70 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histopathologically confirmed colorectal cancer patients with curative resection
  • ECOG performance status 0-2
  • Provision of signed, written and dated informed consent prior to any study specific procedures
  • Receiving adjuvant chemotherapy with FOLFOX (5-FU, leucovorin, oxaliplatin) regimen

排除标准

  • Having contraindication to dexamethasone
  • Having nausea or vomiting before the start of adjuvant chemotherapy

研究组 & 干预措施

Elderly patients (>= 70 years of age)

Experimental

Dexamethasone 8mg intravenously before chemotherapy

干预措施: Dexamethasone (Drug)

结局指标

主要结局

Complete response (CR)

时间窗: 2 weeks

No emetic episode, no rescue medicine

次要结局

  • Complete control (CC)(2 weeks)
  • Complete protection (CP)(2 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jin Won Kim

Associate Professor

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验

Reduced Dose of Prophylactic Dexamethasone for... | 临床试验